资讯

James Cameron calls Christopher Nolan’s Oppenheimer ‘a moral cop-out’
James Cameron has hit out at rival director Christopher Nolan ’s Oscar-winning film Oppenheimer, calling it a “moral cop-out” ...
Oppenheimer在CMS决定后重申Abbott股票评级为"优于大盘"
Investing.com - Oppenheimer在美国医疗保险和医疗补助服务中心 (CMS)对三尖瓣经导管边缘对边缘修复术 (T-TEER)作出最终决定后，重申了对雅培实验室 ( Abbott Laboratories ) (NYSE: ABT )的"优于大盘"评级和140美元的目标价。
Oppenheimer's John Stoltzfus: Biggest worry for markets is tariffs
John Stoltzfus, Oppenheimer chief investment strategist, joins CNBC's 'Squawk on the Street' to discuss how market could ...
FandomWire2 小时
“I’m just stupid that way”: Why James Cameron’s ‘Ghosts of Hiroshima’ Won’t ...
Avatar director James Cameron revealed that he wasn't a fan of Christopher Nolan's Oppenheimer because Nolan didn't show the ...
James Cameron slams 'Oppenheimer' avoiding aftermath of atomic bombings on Japan as 'moral ...
Filmmaker James Cameron calls "Oppenheimer" a "moral cop-out" for avoiding bombing aftermath scenes, as he develops his own ...
James Cameron Takes Issue with Christopher Nolan's Approach in “Oppenheimer”: It's a ...
“Yeah…it’s interesting what he stayed away from,” Cameron, 70, told Deadline of Nolan, 54, when asked if he was surprised Oppenheimer won seven Oscars and grossed nearly $1 billion. “Look, I love the ...
Oppenheimer下调Capricor股票目标价，因FDA审查担忧
Investing.com - Oppenheimer周一将Capricor Therapeutics (NASDAQ: CAPR )的目标价从43.00美元下调至22.00美元，同时维持对该股的"优于大市"评级。此次调整发生之际，CAPR股价在过去一周下跌超过33%，尽管 InvestingPro 数据显示该股在过去一年仍上涨了76%。
Oppenheimer Reaffirms Outperform on Revolution Medicines, Cites PDAC and NSCLC Trial Progress
Revolution Medicines, Inc. (NASDAQ:RVMD) ranks among the 30 stocks expected to beat the market by 20 percentage points this year.
James Cameron Says Christopher Nolan’s ‘Oppenheimer’ Was a ‘Moral Cop Out’: ‘It ...
After Christopher Nolan’s Oppenheimer broke records at the box office, James Cameron is working on a nuclear war film of his ...